Characteristics of molecular subtypes and cinical outcomes in the immunotherapy Queue of extensive-stage small cell lung cancer patients
In a diverse cohort of SCLC patients receiving immunotherapy, the subtype-I showed significant survival advantages while the subtype-A experienced a worse survival.
Authors
- Fengge Zhou (ORCID: https://orcid.org/0000-0001-7159-6647)
- J Li (ORCID: https://orcid.org/0000-0003-3177-4335)
- Renya Zeng (ORCID: https://orcid.org/0000-0003-0667-8165)
- Yuanliu Nie
- Jixian Li (ORCID: https://orcid.org/0000-0002-6880-7252)
- Wentao Zhang (ORCID: https://orcid.org/0000-0003-4087-7280)
- Yi Zhao
- Zhe Yang (ORCID: https://orcid.org/0000-0003-4082-6088)
- Alei Feng
- Qiang Li
Institutions
- Shandong University (CN)
- Shandong Provincial Hospital (CN)
Publication Details
- Journal
- BMC Pulmonary Medicine
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1186/s12890-024-03221-4
- Citations
- 2
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Beijing Xisike Clinical Oncology Research Foundation